Suchergebnisse - "Hsu, Ann"

PubPharm (10)

1

Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease

enthalten in: Journal of the neurological sciences | 2017

von Tetrud, J. | Nausieda, P. | Kreitzman, D. | +11

2

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease

enthalten in: Parkinsonism & related disorders | 2014

von Pahwa, R. | Lyons, K. | Hauser, R. | +64

3

Population pharmacodynamics of IPX066 : an oral extended-release capsule formulation of carbidopa-levodopa, and immediate-release carbidopa-levodopa in patients with advanced Parkinson's disease

enthalten in: Journal of clinical pharmacology | 2013

von Mao, Z. | Hsu, A. | Gupta, S. | +1

4

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations : a phase 3 randomised, double-blind trial

enthalten in: The Lancet. Neurology | 2013

von Hauser, R. | Hsu, A. | Kell, S. | +7

CommentIn: Lancet Neurol. 2013 Apr;12(4):325-6. - PMID 23485609

5

Older HIV-positive adults in Xiangxi, China : infection modes and associated risk factors

enthalten in: Sexually transmitted diseases | 2012

von Chen, X. | Li, X. | Qin, B. | +6

6

Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease

enthalten in: Movement disorders : official journal of the Movement Disorder Society | 2011

von Hauser, R. | Ellenbogen, A. | Metman, L. | +6

CommentIn: Mov Disord. 2012 Apr;27(4):579. - PMID 22344707

7

Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine

enthalten in: The Journal of infectious diseases | 2004

von Kempf, D. | King, M. | Bernstein, B. | +7

8

Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children

enthalten in: The Pediatric infectious disease journal | 2003

von Sáez-Llorens, X. | Violari, A. | Deetz, C. | +17

9

Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients

enthalten in: Antimicrobial agents and chemotherapy | 2003

von Hsu, A. | Isaacson, J. | Brun, S. | +11

10

Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients

enthalten in: The Journal of infectious diseases | 2002

von Benson, C. | Deeks, S. | Brun, S. | +17

1
[1]